BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Amitriptyline

the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.

299+ PubMed studies analyzed · 50 RCTs · Evidence Score: 48.9

Research Domains

Amitriptyline has been studied across 20 research domains including 💊 Pain, 🌤️ Mood & Depression, 😴 Sleep, 🧠 Focus & Attention, ❤️ Cardiovascular. The primary research focus is 💊 Pain with 26% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Amitriptyline, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Nortriptyline
53 shared targets
Mianserin
46 shared targets
Quetiapine
40 shared targets
Cyproheptadine
47 shared targets
Promethazine
40 shared targets
Pergolide
34 shared targets
Amoxapine
44 shared targets
Cinnarizine
31 shared targets
Metergoline
42 shared targets
Maprotiline
34 shared targets
Loading evidence profile...

This evidence profile for Amitriptyline is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.